Head-to-head
Ivim Health vs Noom Med
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. Noom Med is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Ivim Health is $224 a month all-in for semaglutide; Noom Med is $199. Over twelve months that is $2,688 against $2,388. Value Scores are 53.1 and 73.1 out of 100.
Semaglutide
Plan pages: Ivim Health plans · Noom Med plans
At 2.4 mg/week, Ivim Health is $224 a month all-in and Noom Med is $199 — $25 apart, or $300 across a year. Over twelve months the totals are $2,688 (billed monthly) and $2,388 (billed monthly).
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Noom Med charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Ivim Health | Rank | Noom Med | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $149 | 7/32 | $199 | 17/32 | Ivim Health by $50 |
| 0.5 mg | — | — | $199 | 12/21 | only Noom Med publishes |
| 1 mg | — | — | $199 | 12/21 | only Noom Med publishes |
| 1.7 mg | — | — | $199 | 12/21 | only Noom Med publishes |
| 2.4 mg | $149 | 6/29 | $199 | 14/29 | Ivim Health by $50 |
Noom Med is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Ivim Health sits 14 of 29 on all-in monthly cost and Noom Med sits 10. There are 3 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Ivim Health is $95 above the cheapest semaglutide program on record. Noom Med is $70 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Ivim Health undercuts it by $125, Noom Med by $150. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Ivim Health | Noom Med | Cheaper |
|---|---|---|---|
| Month to month | $149 | $199 | Ivim Health by $50 |
| Settled dose | Ivim Health | Noom Med | Difference |
|---|---|---|---|
| 0.25 mg | $2,688 | $2,388 | $300 apart |
| 0.5 mg | — | $2,388 | one side unpriced |
| 1 mg | — | $2,388 | one side unpriced |
| 1.7 mg | — | $2,388 | one side unpriced |
| 2.4 mg | $2,688 | $2,388 | $300 apart |
Ivim Health publishes no rate for 3-month term, 6-month term, 12-month term; Noom Med publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $2,688 on Ivim Health and $2,388 on Noom Med. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 3 of the 5 doses, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 53.1 for Ivim Health and 73.1 for Noom Med, against a semaglutide category floor of $129. Noom Med leads by 20.0 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Ivim Health | 40.3 | 12.8 | 0 | 0 | 53.1 |
| Noom Med | 45.4 | 12.8 | 10 | 5 | 73.1 |
Where the two programs differ
All-in monthly
Noom Med is cheaper month to month — $199 against $224, a gap of $25 every month, or $300 across a year if both rates hold.
Cancellation terms
Cancellation differs: Ivim Health states Cancel anytime, while Noom Med states Per plan terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Ivim Health asks for Month-to-month; Noom Med asks for Program-based. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Noom Med charges one price at every dose; Ivim Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Membership fee
Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $2,688 for Ivim Health and $2,388 for Noom Med. Noom Med is lower by $300 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
Noom Med Official site
Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
It names its compounding pharmacy — Partner pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — noom.com program page capture 2026-08-08
Watch: Noom's program bundling changes frequently; confirm what the quoted figure includes.
Which molecules each one carries
Ivim Health carries tirzepatide at $353 a month and semaglutide at $224 a month.
Noom Med carries semaglutide at $199 a month; does not offer tirzepatide.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Ivim Health does not publish
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
Noom Med does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
Ask Ivim Health and Noom Med for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Noom Med Official site wins this matchup. If you expect to titrate to the top of the ladder, noom med's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, noom med carries no membership.
Both figures should be checked at the provider's own checkout before you pay. Ivim Health's semaglutide price is provider-stated as of 2026-08-05; Noom Med's is provider-stated as of 2026-08-08.
Questions
Is Ivim Health or Noom Med cheaper for semaglutide?
Noom Med is cheaper on all-in monthly cost at 2.4 mg/week: $199 against $224, a difference of $25 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Ivim Health versus Noom Med?
Ivim Health works out to $2,688 across twelve months and Noom Med to $2,388, on the plan terms each publishes.
Does Ivim Health or Noom Med raise the price as the dose goes up?
Ivim Health: yes, it prices by dose. Noom Med: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Ivim Health and Noom Med differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Ivim Health and Noom Med names its pharmacy?
Noom Med does — Partner pharmacies. Ivim Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Ivim Health and Noom Med prices?
Ivim Health's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Noom Med's is provider-stated, captured 2026-08-08. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Ivim Health official site · Noom Med official site. Compounded tirzepatide and semaglutide are not FDA-approved products.